Suzhou Junjing Biosciences Co., Ltd.

This study tested a new drug called WJ13405 in 14 people with advanced non-small cell lung cancer that had stopped responding to standard treatments. The goal was to check the drug's safety and see if it could shrink tumors. The trial was stopped early, so results are limited.

This study tested an experimental drug called WJ05129 in people with advanced solid tumors that had spread or could not be removed by surgery. The goal was to find a safe dose and see if the drug could shrink tumors. The trial was stopped early after enrolling 26 participants. It…